Neoral C2 monitoring in pediatric liver transplant recipients

被引:30
作者
Dunn, S [1 ]
Falkenstein, K [1 ]
Cooney, G [1 ]
机构
[1] Alfred I DuPont Hosp Children, Wilmington, DE USA
关键词
D O I
10.1016/S0041-1345(01)02318-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:3094 / 3095
页数:2
相关论文
共 8 条
  • [1] Nof-11: A one-year pediatric randomized double-blind comparison of neoral versus sandimmune in orthotopic liver transplantation
    Alvarez, F
    Atkison, PR
    Grant, DR
    Guilbault, N
    Jones, AB
    Kim, PSW
    Kneteman, NM
    Laurin, L
    Martin, SR
    Murphy, GF
    Paradis, K
    Shapiro, J
    Smith, LJ
    Superina, RA
    [J]. TRANSPLANTATION, 2000, 69 (01) : 87 - 92
  • [2] Impact of absorption profiling on efficacy and safety of cyclosporin therapy in transplant recipients
    Belitsky, P
    Dunn, S
    Johnston, A
    Levy, G
    [J]. CLINICAL PHARMACOKINETICS, 2000, 39 (02) : 117 - 125
  • [3] Pharmacokinetics of an oral solution of the microemulsion formulation of cyclosporine in maintenance pediatric liver transplant recipients
    Dunn, S
    Cooney, G
    Sommerauer, J
    Lindsay, C
    McDiarmid, S
    Wong, RL
    Chang, CT
    Smith, HT
    Choc, MG
    [J]. TRANSPLANTATION, 1997, 63 (12) : 1762 - 1767
  • [4] Absorption characteristics of a microemulsion formulation of cyclosporine in de novo pediatric liver transplant recipients
    Dunn, SP
    Cooney, GF
    Kulinsky, A
    Falkenstein, K
    Pierson, A
    Elder, CA
    Meligeni, J
    [J]. TRANSPLANTATION, 1995, 60 (12) : 1438 - 1442
  • [5] DUNN SP, 1997, LIVER TRANSPLANT SUR, V3, P1
  • [6] DUNN SP, 2000, TRANSPLANT P SA3, V32, P205
  • [7] Variable oral absorption of cyclosporine - A biopharmaceutical risk factor for chronic renal, allograft rejection
    Kahan, BD
    Welsh, M
    Schoenberg, L
    Rutzky, LP
    Katz, SM
    Urbauer, DL
    VanBuren, CT
    [J]. TRANSPLANTATION, 1996, 62 (05) : 599 - 606
  • [8] Levy GA, 2000, TRANSPLANTATION, V69, pS387